The Discounted Cash Flow (DCF) valuation of Gritstone Oncology Inc (GRTS) is (40.64) USD. With the latest stock price at 0.03 USD, the upside of Gritstone Oncology Inc based on DCF is -126298.2%.
Based on the latest price of 0.03 USD and our DCF valuation, Gritstone Oncology Inc (GRTS) is a sell. selling GRTS stocks now will result in a potential gain of 126298.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 7.2% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (75.19) - (28.44) | (40.64) |
| Upside | -233615.5% - -88435.3% | -126298.2% |